Sept. 3, 2019 11:00 UTC CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced presentations at the following investor conferences during the months of September and early October: H.C. Wainwright 21st Annual Global Investment Conference Corporate update … Read More..
WAYNE, Pa., Sept. 3, 2019 /PRNewswire/ -- Zyla Life Sciences (ZCOR) ("Zyla"), a commercial-stage life sciences company, announced that Bob Radie, president and chief executive officer of Zyla, will give a corporate presentation and participate in a panel at the 2019 Disruptive Growth Conference. The presentation will be at 11:20 a.m. and the panel will take… Read More..
Company engages Jefferies LLC in response to strategic inbound interest NEW YORK and CLEVELAND, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced that it has retained Jefferies LLC as its financial advisor to assist with the review of… Read More..